✦ LIBER ✦

Prostate carcinoma: Radiation treatment of the primary and regional lymphatics

✍ Scribed by Dennis R. Hill; Quintous E. Crews Jr.; Patrick C. Walsh

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 380 KB
Volume: 34
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197407)34:1<156::aid-cncr2820340123>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regional hyperthermia in the treatment o

Regional hyperthermia in the treatment of primary hepatic carcinoma

✍ Haiyan Ge; Jiaoling Huang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

External beam radiation therapy of prima

External beam radiation therapy of primary carcinoma of the prostate

✍ Malcolm A. Bagshaw; Gordon R. Ray; David A. Pistenma; Ronald A. Castellino; Edwi 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Primary radiation treatment of colloid c

Primary radiation treatment of colloid carcinoma of the breast: A case report

✍ Todd H. Wasserman; Edward A. Sickles; Theodore L. Phillips 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Primary radiation therapy in the treatme

Primary radiation therapy in the treatment of squamous cell carcinoma of the soft palate

✍ David Horton; Luu Tran; Peter Greenberg; Michael T. Selch; Robert G. Parker 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

Hypophysectomy in the treatment of disse

Hypophysectomy in the treatment of disseminated prostate carcinoma

✍ Gerald D. Silverberg 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

Novel strategies and therapeutics for th

Novel strategies and therapeutics for the treatment of prostate carcinoma

✍ Michael J. Morris; Howard I. Scher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

An increased understanding of the biology of prostate carcinoma has led to the clinical evaluation of mechanism-based and targeted therapies. Modulating the immune system has been pursued through the use of both active and passive immunity as well as the ex vivo genetic manipulation of effector cell